MedPath

Uthealth Houston

Uthealth Houston logo
🇺🇸United States
Ownership
Private
Established
1967-01-01
Employees
11
Market Cap
-
Website
https://www.cizikeyedoctors.org

Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

Phase 2
Active, not recruiting
Conditions
Bilirubin Encephalopathy
Interventions
First Posted Date
2020-10-14
Last Posted Date
2025-01-03
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
134
Registration Number
NCT04584983
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Connecting Seniors to Care

Not Applicable
Completed
Conditions
Dementia
Interventions
Other: meals
Other: AES 8 advanced usage
Other: AES 8 basic usage
First Posted Date
2020-10-09
Last Posted Date
2023-01-11
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
53
Registration Number
NCT04581317
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Phasix Mesh Use in Complex Open Ventral Hernias Study

Not Applicable
Withdrawn
Conditions
Ventral Hernia
Interventions
Procedure: Repair of ventral hernia using biologic mesh
Procedure: Repair of ventral hernia using suture repair or synthetic mesh
First Posted Date
2020-10-08
Last Posted Date
2023-06-22
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT04580524
Locations
🇺🇸

Lyndon B. Johnson General Hospital, Houston, Texas, United States

🇺🇸

Memorial Hermann Hospital-Texas Medical Center, Houston, Texas, United States

High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache

Not Applicable
Terminated
Conditions
Cluster Headache
Interventions
Drug: multivitamin
Drug: Placebo
First Posted Date
2020-09-30
Last Posted Date
2025-02-06
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
27
Registration Number
NCT04570475
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Reducing Costs by Deprescribing Medications

Not Applicable
Completed
Conditions
Deprescribing
Polypharmacy
Adverse Drug Reaction
Interventions
Behavioral: Deprescribing Intervention
Behavioral: Usual Care
First Posted Date
2020-09-17
Last Posted Date
2022-11-22
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
419
Registration Number
NCT04553107
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Cost Effectiveness Analysis of a Randomized Control Trial of q3h vs. q4h Albuterol as Discharge Criteria From the Hospital for Pediatric Asthma Exacerbations

Not Applicable
Withdrawn
Conditions
Asthma in Children
Interventions
Behavioral: q3h albuterol
First Posted Date
2020-09-09
Last Posted Date
2021-08-19
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT04542005

Post Operative Pain Control for Distal Radius Surgery: Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours ?

Phase 4
Withdrawn
Conditions
Post Operative Pain
Interventions
Drug: Group B (Bupivacaine HCL plus supraclavicular block)
Drug: Group A (Exparel plus supraclavicular block)
Drug: Group C(supraclavicular block only)
First Posted Date
2020-09-07
Last Posted Date
2021-10-29
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT04540848

Preterm Functional Early Enteral Development (FEED) Trial on Respiratory Support

Not Applicable
Conditions
Premature Birth
Interventions
Dietary Supplement: Oral Feed
Dietary Supplement: Usual care
First Posted Date
2020-08-28
Last Posted Date
2022-05-23
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
50
Registration Number
NCT04531566
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease

Phase 2
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2020-08-10
Last Posted Date
2024-07-26
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
45
Registration Number
NCT04506073
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Transcutaneous Intercostal Nerve Stimulation in Spinal Cord Injury

Not Applicable
Withdrawn
Conditions
SCI - Spinal Cord Injury
Neuropathic Pain
Interventions
Device: Sham protocol
Device: TINS Active protocol
First Posted Date
2020-08-10
Last Posted Date
2021-10-22
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT04506099
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath